← 產業報告目錄

Pen Needles Market, By Type of Needle (Standard Pen Needles and Safety Pen Needles), By Needle Length (4mm, 5mm, 6mm, 8mm,10mm, and 12mm), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版商 Coherent Market Insights出版日期 2026-07-28頁數 257報告編號 CMR-91ae912c61

授權報價

Single User Price$4,500 USD
Site License Price$7,000 USD
Enterprisewide Price (Global Site License)$10,000 USD
洽詢購買 申請 Sample

報告摘要

The Pen Needles Market is estimated to be valued at USD 3.14 Bn in 2026 and is expected to reach USD 6.28 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 10.4% from 2026 to 2033. The market is undergoing a major transformation driven by rising prevalence of diabetes, increasing adoption of insulin therapy, and growing emphasis on convenient self-administration solutions. Pen needles, including standard, safety, extra-thin, and short-length variants, enable patients to administer insulin efficiently while addressing pain reduction, dosing accuracy, needle-stick prevention, and safety standards. The market includes a wide array of product applications like insulin delivery, glucagon-like peptide-1 therapy, growth hormone treatment, osteoporosis management, fertility treatment, and chronic disease injections. Patients and healthcare providers are focusing on comfortable injection experiences and user-friendly delivery approaches to enhance treatment adherence, ensure accurate dosing, and maintain quality of life. Advancements in needle-tip geometry, ultra-thin wall technology, and safety mechanisms are improving product performance, especially among pediatric, elderly, and needle-anxious patients. In addition, the growing use of disposable insulin pens, home-based care, and diabetes education programs helps optimize injection technique and patient compliance, thereby improving clinical outcomes and reducing burden of long-term disease management. Market Dynamics The market is witnessing momentum owing to the expanding diabetic population, rising use of injectable therapies, and growing preference for convenient self-administration devices. The market’s growth is largely driven by patients, hospitals, and diabetes care providers seeking easy-to-use injection accessories, particularly for insulin, glucagon-like peptide-1 medicines, growth hormone therapies, fertility drugs, and other treatments requiring frequent subcutaneous administration. Shorter needle lengths, finer gauges, thin-wall designs, and safety mechanisms play a central role in product development, thereby helping reduce injection discomfort, improve dose delivery, prevent needle-stick injuries, and support treatment adherence. The rising focus on home-based diabetes management, patient convenience, and safe injection practices is strengthening demand for pen needles. The expansion of insulin pen usage is fueling market growth. This is mainly driven by availability of disposable and reusable pens, increasing awareness of injection techniques, and broader use of ultra-fine needles designed for diverse patient groups. Product developments involving improved bevel geometry, protective shielding, and low-friction coatings help enhance penetration, reduce pain perception, and support consistent medicine administration. The rising demand for safer injection solutions is also propelling the market. Endocrinologists, diabetes educators, pharmacists, nurses, caregivers, medical device manufacturers, and home healthcare providers play a crucial role in recommending and supplying pen needles. As diabetes management becomes patient-centered, the market is expected to benefit from wider access, improved safety features, stronger education initiatives, and the introduction of comfortable, compatible, and user-friendly needle solutions. Key Features of the Study • This report provides in-depth analysis of the Pen Needles Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the Pen Needles Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Novo Nordisk A/S, Becton, Dickinson and Company, Ypsomed AG, UltiMed, Inc., TERUMO CORPORATION, HTL-STREFA, Owen Mumford Ltd., B. Braun Melsungen AG, Allison Medical, Inc., Hindustan Syringes and Medical Devices Ltd., and Artsana S.p.a. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The Pen Needles Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Pen Needles Market Market Segmentation • By Type of Needle (Revenue, USD Bn, 2021-2033) o Standard Pen Needles o Safety Pen Needles • By Needle Length (Revenue, USD Bn, 2021-2033) o 4mm o 5mm o 6mm o 8mm o 10mm o 12mm • By Distribution Channel (Revenue, USD Bn, 2021-2033) o Retail Pharmacy o Hospital Pharmacy o Online Pharmacies • Global Pen Needles Market, By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players Insights o Novo Nordisk A/S o Becton, Dickinson and Company o Ypsomed AG o UltiMed, Inc. o TERUMO CORPORATION o HTL-STREFA o Owen Mumford Ltd. o Braun Melsungen AG o Allison Medical, Inc. o Hindustan Syringes and Medical Devices Ltd. o Artsana S.p.a.
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Type of Needle  Market Snapshot, By Needle Length  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Disease Type Approval o Collaboration/Merge/Acquisition o Regulatory Landscape o PEST Analysis o Porter’s Five Forces Analysis o Epidemiology o Robust Pipeline Analysis 4. Global Pen Needles Market, By Type of Needle, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Standard Pen Needles  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Safety Pen Needles  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 5. Global Pen Needles Market, By Needle Length, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o 4mm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o 5mm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o 6mm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o 8mm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o 10mm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o 12mm  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 6. Global Pen Needles Market, By Distribution Channel, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Retail Pharmacy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Hospital Pharmacy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion) 7. Global Pen Needles Market, By Region, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033 o Regional Trends  North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type of Needle, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Needle Length, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type of Needle, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Needle Length, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type of Needle, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Needle Length, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type of Needle, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Needle Length, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type of Needle, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Needle Length, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type of Needle, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Needle Length, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profile  Novo Nordisk A/S o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Becton, Dickinson and Company o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Ypsomed AG o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  UltiMed, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  TERUMO CORPORATION o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  HTL-STREFA o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Owen Mumford Ltd. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  B. Braun Melsungen AG o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Allison Medical, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Hindustan Syringes and Medical Devices Ltd. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Artsana S.p.a. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies o Analyst Views 9. Section o References o Research Methodology o About Us
圖表清單 List of Tables & Figures
NA NA

提及公司

o Novo Nordisk A/So BectonDickinson and Companyo Ypsomed AGo UltiMedInc.o TERUMO CORPORATIONo HTL-STREFAo Owen Mumford Ltd.o Braun Melsungen AGo Allison MedicalInc.o Hindustan Syringes and Medical Devices Ltd.o Artsana S.p.a.

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們